Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Looking for Solubilizers? Find Solubilizers Agents used in Topotecan Hydrochloride to address drug delivery challenges on PharmaCompass.

Excipients
Solubilizers
Topotecan Hydrochloride

Capsule
Cream / Lotion / Ointment
Dry Syrup
Emulsion
Gel
Granule / Pellet
Injectable / Parenteral
Nasal Solution
Ophthalmic Solution
Paste
Shampoo
Softgel Capsule
Solution
Suppository
Suspension
Syrup
Tablet
Topical Film
Transdermal patches

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

View Presentation

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

xyz-pharma-m-Default-Wallpaper

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-Default-Wallpaper

Contact Supplier

Topotecan Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

18 API Suppliers, 8 USDMF, 1 EU WC, 4 KDMF, 3 NDC API, 12 Listed Suppliers, $ API Reference Price

18 API Suppliers
8 USDMF
1 EU WC
4 KDMF
3 NDC API
12 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

15 Drugs in Development

15 Drugs in Development

INTERMEDIATES

3 Intermediates Suppliers

3 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

72 FDF Dossiers, 22 FDA Orange Book, 31 Europe, 5 Canada, 4 Australia, 4 South Africa, 6 Listed Dossiers

72 FDF Dossiers
22 FDA Orange Book
31 Europe
5 Canada
4 Australia
4 South Africa
6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - EQ 1MG BASE/ML (EQ 1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INTRAVENOUS - EQ 3MG BASE/3ML (EQ 1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INTRAVENOUS - EQ 4MG BASE/4ML (EQ 1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INTRAVENOUS - EQ 4MG BASE/4ML (EQ 1MG BASE/ML), INJECTABLE;INJECTION - EQ 4MG BASE/VIAL, CAPSULE;ORAL - EQ 0.25MG BASE, CAPSULE;ORAL - EQ 1MG BASE

SOLUTION;INTRAVENOUS - EQ 1MG BASE/ML (EQ 1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION;INTRAVENOUS - EQ 3MG BASE/3ML (EQ 1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION;INTRAVENOUS - EQ 4MG BASE/4ML (EQ 1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION;INTRAVENOUS - EQ 4MG BASE/4ML (EQ 1MG BASE/ML)
INJECTABLE;INJECTION - EQ 4MG BASE/VIAL
CAPSULE;ORAL - EQ 0.25MG BASE
CAPSULE;ORAL - EQ 1MG BASE

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 13 SPI Pharma, 6 DKSH, 1 Faran Shimi Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 1 Actylis, 2 BASF, 3 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 6 Kerry, 3 Lonza Capsugel, 2 Microlex e.U, 1 Pluviaendo, 1 Qualicaps, 5 Roquette, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries

1 Rochem International Inc
13 SPI Pharma
6 DKSH
1 Faran Shimi Pharmaceutical
1 Pfanstiehl
4 ACG Worldwide
1 Actylis
2 BASF
3 Gangwal Chemicals
1 Ingredion Pharma Solutions
6 Kerry
3 Lonza Capsugel
2 Microlex e.U
1 Pluviaendo
1 Qualicaps
5 Roquette
1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shijiazhuang Huaxu Pharmaceutical
1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

21 Fillers, Diluents & Binders, 10 Taste Masking, 10 Chewable & Orodispersible Aids, 9 Direct Compression, 8 Empty Capsules, 8 Co-Processed Excipients, 6 Coating Systems & Additives, 5 Thickeners and Stabilizers, 5 Parenteral, 3 Disintegrants & Superdisintegrants, 3 Granulation, 2 Film Formers & Plasticizers, 2 Solubilizers, 2 Coloring Agents, 1 API Stability Enhancers, 1 Topical

21 Fillers, Diluents & Binders
10 Taste Masking
10 Chewable & Orodispersible Aids
9 Direct Compression
8 Empty Capsules
8 Co-Processed Excipients
6 Coating Systems & Additives
5 Thickeners and Stabilizers
5 Parenteral
3 Disintegrants & Superdisintegrants
3 Granulation
2 Film Formers & Plasticizers
2 Solubilizers
2 Coloring Agents
1 API Stability Enhancers
1 Topical

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 21 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
21 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 20 Finished Drug Prices

1 US Medicaid Prescriptions
20 Finished Drug Prices

MARKET PLACE

3 APIs, 5 FDF Dossiers

3 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents, 3 Health Canada Patents

2 US Patents
3 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 USP, 4 Others

2 USP
4 Others

$ API Ref.Price (USD/KG) : 760,431 Xls

Filters

Reset all filters

Topotecan Hydrochloride

Filters

FILTER :

filter Company Reset all filters

8 All

01 3SPI Pharma

02 5BASF

filter Capability Reset all filters

8 All

01 1Capsule

02 1Cream / Lotion / Ointment

03 1Emulsion

04 1Gel

05 1Granule / Pellet

06 1Softgel Capsule

07 2Tablet

filter Country Reset all filters

8 All

01 5Germany

02 3U.S.A

01

SPI Pharma

U.S.A

CPhI India 2024

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Capsule, Granule / Pellet, Tablet

Grade : Oral

Brand Name : TAP®

Application : Solubilizers

Excipient Details : TAP® pellets are spherical cores made of tartaric acid used for solubility enhancement of drugs exhibiting poor solubility in alkali environments.

Pharmacopoeia Ref : NA

Technical Specs : Bulk density: 0.8-1.1

Ingredient(s) : Tartaric Acid

Dosage Form : Capsule, Granule / Pellet, Tablet

Grade : Oral

SPI Pharma has been solving formulation challenges using superior functional materials.

Ingredient(s) : Tartaric Acid

Dosage Form : Capsule, Granule / Pellet, Tablet

Category : Solubilizers

Brand : TAP®

Applications : TAP® pellets are spherical cores made of tartaric acid used for solubility enhancement of drugs exhibiting poor solubility in alkali environments.

Pharmacopoeia Ref : NA

Technical Specs : Bulk density: 0.8-1.1

Grade : Oral

TAP

Excipients Web Link

Digital Content

02

BASF

KOLLIWAX GMS II

Fi Europe 2024

Not Confirmed

BASF

Germany

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Dosage Form : Cream / Lotion / Ointment, Emulsion, Gel, Softgel Capsule, Tablet

Grade :

Brand Name : Kolliwax GMS II

Application : Coating Systems & Additives, Solubilizers, Topical

Excipient Details : Co-emulsifier, viscosity enhancer & anti-tacking agent

Pharmacopoeia Ref : Ph. Eur.: Glyceryl monostearat...

Technical Specs :

Ingredient(s) : Glyceryl Monostearate With Mono & Di Glycerides

Dosage Form : Cream / Lotion / Ointment, Emulsion, Gel, Softgel Capsule, Tablet

Grade :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Ingredient(s) : Glyceryl Monostearate With Mono & Di Glycerides

Dosage Form : Cream / Lotion / Ointment, Emulsion, Gel, Softgel Capsule, Tablet

Category : Coating Systems & Additives, Solubilizers, Topical

Brand : KOLLIWAX GMS II

Applications : Co-emulsifier, viscosity enhancer & anti-tacking agent

Pharmacopoeia Ref : Ph. Eur.: Glyceryl monostearate 40-55 (type II), USP-NF: Mono- and di-glycerides

Technical Specs : Not Available

Grade : Not Available

Excipients Web Link

Digital Content

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?